SRO9 Antibody

What is SRO9 and why are antibodies against it important for research?

SRO9 belongs to a class of La motif-containing proteins present in all sequenced eukaryotic genomes. In Saccharomyces cerevisiae (yeast), SRO9 functions in diverse cellular processes including transcription by RNA polymerase II, translation, and mRNA stability . SRO9 antibodies are crucial research tools that enable detection, quantification, and localization of SRO9 in experimental systems, allowing researchers to investigate its functional roles in gene expression pathways.

What are the known cellular functions of SRO9 that can be studied using SRO9 antibodies?

SRO9 plays multiple roles in gene expression, making it an important target for antibody-based research. SRO9 was originally identified in genetic screens as a suppressor of mutants in the secretory pathway, bud formation, and actin/tropomyosin . Subsequent research demonstrated that SRO9:

• Binds to RNA and associates with translating ribosomes

• Functions in transcription by RNA polymerase II

• May act as a molecular chaperone stabilizing mRNAs

• Influences mRNP rearrangements for efficient translation

• Shuttles between nucleus and cytoplasm

• Is recruited to actively transcribed genes

These diverse functions can be investigated using SRO9 antibodies in techniques such as immunoprecipitation, ChIP, and immunofluorescence.

How does SRO9 differ from authentic La proteins, and what implications does this have for antibody specificity?

SRO9 contains a phylogenetically different La motif compared to authentic La proteins. While authentic La proteins typically have an N-terminal La motif, SRO9 belongs to a class where the La motif can be positioned N-terminally, centrally, or C-terminally . Moreover, these proteins display no sequence homology except in the La motif itself.

For antibody development and application, this means:

• Antibodies must be carefully designed to target unique epitopes specific to SRO9

• Cross-reactivity testing against other La motif-containing proteins is essential

• Validation in knockout/knockdown models is recommended to confirm specificity

• Researchers should be aware of potential cross-reactivity with the SRO9 homolog Slf1, which shares approximately 30% identity throughout its amino acid sequence

How can SRO9 antibodies be utilized to investigate its nucleocytoplasmic shuttling activity?

SRO9 shuttles between the nucleus and cytoplasm, with its export from the nucleus being dependent on mRNA export pathways . To investigate this dynamic process:

Methodological approach with SRO9 antibodies:

• Use indirect immunofluorescence with SRO9 antibodies to track localization under different conditions

• Employ temperature-sensitive mRNA export mutants (e.g., mex67-5) to block mRNA export at non-permissive temperatures

• Compare SRO9 localization at permissive (30°C) versus non-permissive (37°C) temperatures

• Quantify nuclear accumulation of SRO9 when mRNA export is blocked

As demonstrated in research, SRO9 localizes exclusively to the cytoplasm at steady state but accumulates in the nucleus when mRNA export is blocked in mex67-5 cells at 37°C . This approach can be extended to investigate how various cellular conditions and treatments affect SRO9's nucleocytoplasmic distribution.

What techniques can be employed using SRO9 antibodies to study its association with actively transcribed genes?

SRO9's presence at actively transcribed genes can be investigated using chromatin immunoprecipitation (ChIP) with SRO9 antibodies. A comprehensive methodological approach includes:

Experimental design:

• Culture cells under conditions where a model gene (e.g., GAL1) is either repressed or induced

• Perform chromatin crosslinking with formaldehyde

• Immunoprecipitate SRO9-associated chromatin using specific antibodies

• Analyze the association of SRO9 with the target gene by PCR or sequencing

Example of SRO9 recruitment to the GAL1 gene:

This approach has revealed that SRO9 is recruited to the GAL1 locus only when transcription is active (galactose medium) and not when it is repressed (glucose medium) . Furthermore, the association increases when mRNA export is blocked and SRO9 accumulates in the nucleus.

How can SRO9 antibodies be used to investigate protein-protein interactions in the context of mRNA processing?

SRO9 interacts with various protein complexes involved in nuclear and cytoplasmic steps of gene expression. To investigate these interactions:

Methodological strategy:

• Perform tandem affinity purification using SRO9 antibodies

• Conduct co-immunoprecipitation experiments under various conditions

• Analyze co-purifying proteins by SDS-gel electrophoresis and Western blotting

• Validate interactions using reciprocal immunoprecipitation

Research has employed such approaches to demonstrate SRO9's interactions with:

• RNA polymerase II components (Rpb1)

• Transcription factors (Ctk1)

• mRNA export factors (Hpr1)

• RNA-binding proteins (Npl3)

These interactions support SRO9's role in connecting transcription, mRNA processing, and translation processes.

What are the optimal protocols for using SRO9 antibodies in chromatin immunoprecipitation (ChIP) experiments?

For effective ChIP experiments using SRO9 antibodies, researchers should consider the following optimized protocol:

ChIP Protocol for SRO9:

• Cell preparation:

  • Culture cells to appropriate density (e.g., OD₆₀₀ of 0.4)

  • For inducible gene studies, use appropriate media (e.g., glucose vs. galactose)

• Crosslinking:

  • Add formaldehyde to a final concentration of 1%

  • Cross-link for 20-25 minutes at appropriate temperature

  • Quench with glycine

• Cell lysis and chromatin preparation:

  • Lyse cells with glass beads by vortexing (6 × 3 minutes with 3-minute breaks on ice)

  • Sonicate to fragment chromatin

  • Remove cell debris by centrifugation

• Immunoprecipitation:

  • Use chromatin lysate corresponding to 14 A₂₈₀ units

  • Immunoprecipitate with 15 μL of IgG-coupled Dynabeads or specific SRO9 antibodies

  • Incubate for 3.5 hours at 20°C

• Washing and elution:

  • Wash beads thoroughly to remove non-specific interactions

  • Elute bound complexes

  • Reverse crosslinking and purify DNA

• Analysis:

  • Analyze by PCR, qPCR, or next-generation sequencing

  • Include appropriate controls (input, IgG control, etc.)

This protocol has been effective in demonstrating SRO9 recruitment to the GAL1 gene during active transcription .

What are the best practices for using SRO9 antibodies in indirect immunofluorescence experiments?

For optimal immunofluorescence detection of SRO9:

Recommended Protocol:

• Sample preparation:

  • Culture cells under appropriate conditions

  • For nucleocytoplasmic shuttling studies, include conditions that block mRNA export (e.g., temperature shift in mex67-5 cells)

• Fixation:

  • Add formaldehyde to 3.3% final concentration

  • Fix for 90 minutes at appropriate temperature

  • Wash and prepare spheroplasts using Zymolyase

• Slide preparation:

  • Apply spheroplasts to polylysine-coated multiwell slides

  • Fix onto slides by consecutive immersions in -80°C methanol (6 minutes) and -80°C acetone (30 seconds)

  • Allow to dry and rehydrate

• Antibody staining:

  • Apply primary antibody (anti-SRO9) for 2 hours

  • Incubate with appropriate secondary antibody (e.g., Alexa488-conjugated) for 1 hour

  • Counterstain nuclear DNA with DAPI

• Imaging:

  • Analyze using fluorescence microscopy

  • Capture multiple fields to ensure representative results

  • Use appropriate filters to distinguish signal from background

This approach has successfully demonstrated SRO9's cytoplasmic localization under normal conditions and its nuclear accumulation when mRNA export is blocked .

How can SRO9 antibodies be used in tandem affinity purification to study associated proteins?

Tandem affinity purification (TAP) using SRO9 antibodies allows isolation of SRO9-containing complexes:

Step-by-step methodology:

• Generation of tagged constructs:

  • Create TAP-tagged SRO9 by integration into the genome

  • Verify expression by Western blotting

• Cell growth and crosslinking:

  • Culture cells to OD₆₀₀ of 0.6

  • If studying condition-dependent interactions, divide cultures for different treatments

  • Crosslink with 1% formaldehyde for 10 minutes

  • Quench with glycine

• Cell lysis:

  • Lyse in high salt buffer (1M NaCl)

  • Use glass beads with vortexing (6 × 3 minutes with breaks)

  • Sonicate and remove debris by centrifugation

• First affinity step:

  • Incubate supernatant overnight with IgG sepharose beads

  • Wash with high salt buffer

  • Cleave immunoprecipitated material with TEV protease

• Analysis of co-purifying proteins:

  • Analyze by SDS-gel electrophoresis

  • Perform Western blotting for proteins of interest

  • Use antibodies against potential interacting partners

This approach has identified interactions between SRO9 and components of transcription machinery (Rpb1, Ctk1), mRNA export factors (Hpr1), and RNA-binding proteins (Npl3) .

How can researchers address potential cross-reactivity between SRO9 antibodies and its homolog Slf1?

SRO9 shares approximately 30% sequence identity with its homolog Slf1, posing challenges for antibody specificity:

Recommended approaches:

• Validation in knockout strains:

  • Compare antibody reactivity in wild-type, Δsro9, and Δslf1 strains

  • Dual knockout controls may be necessary if complementation occurs

• Epitope selection:

  • Target unique regions with minimal homology between SRO9 and Slf1

  • Consider generating antibodies against synthetic peptides from divergent regions

• Pre-absorption strategy:

  • Pre-absorb antibodies with recombinant Slf1 to reduce cross-reactivity

  • Test specificity by Western blotting against both proteins

• Genetic tagging approach:

  • Use epitope-tagged SRO9 and specific anti-tag antibodies

  • This approach has been successfully employed in studies using SRO9-TAP strains

• Control for complementation:

  • Be aware that overexpression of Slf1 decreases SRO9 protein levels

  • Design experiments to account for potential functional redundancy

What are the key considerations when interpreting SRO9 antibody data in gene expression studies?

When interpreting data from experiments using SRO9 antibodies:

Interpretation guidelines:

• Context-dependent localization:

  • SRO9 localizes primarily to the cytoplasm at steady state

  • Nuclear accumulation occurs when mRNA export is blocked

  • Interpret localization data in the context of cellular export competence

• Transcriptional recruitment patterns:

  • SRO9 associates with actively transcribed genes but not with repressed genes

  • Association increases when nuclear export is blocked

  • Consider transcriptional status when interpreting ChIP data

• Redundancy considerations:

  • Genome-wide expression analysis shows minimal changes in Δsro9 cells

  • Likely functional redundancy with Slf1

  • Negative results in single knockout studies should be interpreted cautiously

• Interaction network complexity:

  • SRO9 interacts with components of multiple gene expression processes

  • Consider the broader context of these interactions when interpreting results

  • Data may reflect direct or indirect associations within larger complexes

How can researchers differentiate between SRO9's roles in transcription versus translation when using antibody-based approaches?

Distinguishing SRO9's nuclear versus cytoplasmic functions requires careful experimental design:

Methodological approach:

• Subcellular fractionation:

  • Separate nuclear and cytoplasmic fractions with validated protocols

  • Analyze SRO9 distribution and associated proteins in each fraction

  • Use markers of nuclear (e.g., histones) and cytoplasmic (e.g., cytosolic enzymes) fractions

• Condition-specific analysis:

  • Compare SRO9 interactions under conditions that affect transcription versus translation

  • Use transcription inhibitors (e.g., actinomycin D) versus translation inhibitors (e.g., cycloheximide)

  • Analyze changes in SRO9 interactions under each condition

• Sequential ChIP and RIP:

  • Perform chromatin immunoprecipitation followed by RNA immunoprecipitation

  • Determine if SRO9 associates with both chromatin and RNA

  • Identify whether the same RNA species are bound at the chromatin and in the cytoplasm

• Protein complex analysis:

  • Compare SRO9-associated proteins in nuclear versus cytoplasmic fractions

  • Distinguish between transcription-related (e.g., Rpb1, Ctk1) and translation-related partners

  • Quantify relative association under different conditions

Research insights:
While deletion of SRO9 reduces sensitivity to translation inhibitors (suggesting a role in translation), it can also suppress transcription defects caused by deletion of Rpb4, a non-essential subunit of RNA polymerase II . This dual functionality suggests SRO9 may coordinate transcription and translation processes as part of the mRNA lifecycle.

What emerging technologies might enhance the utility of SRO9 antibodies in research?

Several innovative technologies could expand SRO9 antibody applications:

Advanced methodologies:

• Proximity labeling approaches:

  • BioID or APEX2 fusions with SRO9 combined with antibody detection

  • Allow identification of transient or weak interactions in native cellular contexts

  • Could reveal novel SRO9-interacting proteins in specific compartments

• Super-resolution microscopy:

  • Combining SRO9 antibodies with techniques like STORM or PALM

  • Could provide nanoscale resolution of SRO9 localization

  • May reveal previously undetected subcellular microdomains containing SRO9

• Live-cell imaging with antibody fragments:

  • Using fluorescently labeled nanobodies against SRO9

  • Could enable real-time tracking of SRO9 movement between nucleus and cytoplasm

  • May provide kinetic data on nucleocytoplasmic shuttling

• Single-cell approaches:

  • Combining SRO9 antibody staining with single-cell transcriptomics

  • Could reveal cell-to-cell variability in SRO9 function

  • May identify subpopulations with distinct SRO9 localization patterns

How might SRO9 antibodies contribute to understanding broader RNA processing pathways?

SRO9 antibodies can provide insights into integrated RNA processing:

Research opportunities:

• Coordination of transcription and translation:

  • Investigate whether SRO9 serves as a molecular link between these processes

  • Determine if SRO9 marks specific mRNAs for enhanced translation

  • Study how transcriptional recruitment influences cytoplasmic fate

• Role in stress responses:

  • Examine changes in SRO9 localization and interactions during cellular stress

  • Determine whether SRO9 participates in stress granule formation

  • Investigate potential roles in selective translation during stress

• Evolutionary conservation:

  • Compare SRO9 functions across species using cross-reactive antibodies

  • Determine whether nucleocytoplasmic shuttling is conserved

  • Identify species-specific adaptations in SRO9 function

• Interaction with non-coding RNAs:

  • Investigate whether SRO9 associates with regulatory non-coding RNAs

  • Determine if such interactions influence SRO9's functions in gene expression

  • Study potential roles in non-coding RNA metabolism